BIO-RAD LABORATORIES, INC. (BIO-B) › Cash & EquivalentsBIO-RAD LABORATORIES, INC. (BIO-B) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2007: $161.76M2008: $204.52M2009: $649.94M2010: $906.55M2011: $574.23M2012: $463.39M2013: $331.55M2014: $413.25M2015: $457.55M2016: $456.26M2017: $383.82M2018: $431.53M2019: $660.67M2020: $662.21M2021: $470.78M2022: $434.20M2023: $403.80M2024: $488.10M2025: $529.80M$529.80M2007Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$529.80M+8.5%2024$488.10M+20.9%2023$403.80M-7.0%2022$434.20M-7.8%2021$470.78M-28.9%2020$662.21M+0.2%2019$660.67M+53.1%2018$431.53M+12.4%2017$383.82M-15.9%2016$456.26M-0.3%2015$457.55M+10.7%2014$413.25M+24.6%2013$331.55M-28.5%2012$463.39M-19.3%2011$574.23M-36.7%2010$906.55M+39.5%2009$649.94M+217.8%2008$204.52M+26.4%2007$161.76M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share